Calidi Biotherapeutics, Inc. Files 8-K
Ticker: CLDWW · Form: 8-K · Filed: Feb 5, 2025 · CIK: 1855485
| Field | Detail |
|---|---|
| Company | Calidi Biotherapeutics, Inc. (CLDWW) |
| Form Type | 8-K |
| Filed Date | Feb 5, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001, $5,100,000, $11,200,000, $6,100,000, $5,000,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-identity, name-change
TL;DR
Calidi Biotherapeutics (formerly First Light Acquisition Group) filed an 8-K confirming its identity.
AI Summary
Calidi Biotherapeutics, Inc. filed an 8-K on February 5, 2025, reporting an event on February 4, 2025. The filing indicates a change in the company's former name from First Light Acquisition Group, Inc. to Calidi Biotherapeutics, Inc. on April 6, 2021. The company is in the biological products sector and is incorporated in Delaware.
Why It Matters
This filing confirms the corporate identity and history of Calidi Biotherapeutics, Inc., which is relevant for investors tracking the company's evolution.
Risk Assessment
Risk Level: low — The filing is a routine corporate disclosure and does not contain new financial or operational information that would indicate increased risk.
Key Players & Entities
- Calidi Biotherapeutics, Inc. (company) — Registrant
- First Light Acquisition Group, Inc. (company) — Former company name
- February 4, 2025 (date) — Earliest event date
- February 5, 2025 (date) — Filing date
- April 6, 2021 (date) — Date of name change
- Delaware (jurisdiction) — State of incorporation
- San Diego, California (location) — Principal executive offices
FAQ
What is the exact name of the registrant as specified in its charter?
The exact name of the registrant is Calidi Biotherapeutics, Inc.
On what date was the earliest event reported in this 8-K filing?
The earliest event reported was on February 4, 2025.
When did Calidi Biotherapeutics, Inc. change its name from its former name?
The company changed its name from First Light Acquisition Group, Inc. on April 6, 2021.
In which state is Calidi Biotherapeutics, Inc. incorporated?
Calidi Biotherapeutics, Inc. is incorporated in Delaware.
What is the business address of Calidi Biotherapeutics, Inc.?
The business address is 4475 Executive Drive, Suite 200, San Diego, California 92121.
Filing Stats: 532 words · 2 min read · ~2 pages · Grade level 11.1 · Accepted 2025-02-04 18:15:51
Key Financial Figures
- $0.0001 — ch Registered Common stock, par value $0.0001 per share CLDI NYSE American LLC
- $5,100,000 — Co. Inc., dated October 11, 2024, from $5,100,000 to $11,200,000, and filed a prospectus
- $11,200,000 — ed October 11, 2024, from $5,100,000 to $11,200,000, and filed a prospectus supplement (the
- $6,100,000 — the Sales Agreement for an aggregate of $6,100,000. Prior to the date hereof, the Compan
- $5,000,000 — aggregate sales price of approximately $5,000,000 under the Sales Agreement. A copy of th
Filing Documents
- form8-k.htm (8-K) — 38KB
- ex5-1.htm (EX-5.1) — 12KB
- ex5-1_001.jpg (GRAPHIC) — 19KB
- 0001493152-25-004887.txt ( ) — 251KB
- cldi-20250204.xsd (EX-101.SCH) — 3KB
- cldi-20250204_lab.xml (EX-101.LAB) — 33KB
- cldi-20250204_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CALIDI BIOTHERAPEUTICS, INC. Dated: February 4, 2025 By: /s/ Andrew Jackson Name: Andrew Jackson Title: Chief Financial Officer